Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.

Akaishi T, Morimoto T, Shibao M, Watanabe S, Sakai-Kato K, Utsunomiya-Tate N, Abe K.

Neurosci Lett. 2008 Oct 31;444(3):280-5. doi: 10.1016/j.neulet.2008.08.052. Epub 2008 Aug 22.

PMID:
18761054
[PubMed - indexed for MEDLINE]
2.

Solid-state NMR as a method to reveal structure and membrane-interaction of amyloidogenic proteins and peptides.

Naito A, Kawamura I.

Biochim Biophys Acta. 2007 Aug;1768(8):1900-12. Epub 2007 Apr 5. Review.

PMID:
17524351
[PubMed - indexed for MEDLINE]
Free Article
3.

[Search for antiamyloidogenic compounds based on a nucleation-dependent polymerization model].

Naiki H, Hasegawa K, Ono K, Yamada M.

Yakugaku Zasshi. 2010 Apr;130(4):503-9. Review. Japanese.

PMID:
20371993
[PubMed - indexed for MEDLINE]
Free Article
4.

Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism.

Porat Y, Abramowitz A, Gazit E.

Chem Biol Drug Des. 2006 Jan;67(1):27-37. Review.

PMID:
16492146
[PubMed - indexed for MEDLINE]
5.

Controlling amyloid growth in multiple dimensions.

Dong J, Lu K, Lakdawala A, Mehta AK, Lynn DG.

Amyloid. 2006 Dec;13(4):206-15. Review.

PMID:
17107881
[PubMed - indexed for MEDLINE]
6.

Role of the region 23-28 in Abeta fibril formation: insights from simulations of the monomers and dimers of Alzheimer's peptides Abeta40 and Abeta42.

Melquiond A, Dong X, Mousseau N, Derreumaux P.

Curr Alzheimer Res. 2008 Jun;5(3):244-50. Review.

PMID:
18537541
[PubMed - indexed for MEDLINE]
7.

Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease.

Bastianetto S, Krantic S, Quirion R.

Mini Rev Med Chem. 2008 May;8(5):429-35. Review.

PMID:
18473932
[PubMed - indexed for MEDLINE]
8.

Amyloid-cholinesterase interactions. Implications for Alzheimer's disease.

Inestrosa NC, Dinamarca MC, Alvarez A.

FEBS J. 2008 Feb;275(4):625-32. doi: 10.1111/j.1742-4658.2007.06238.x. Epub 2008 Jan 17. Review.

PMID:
18205831
[PubMed - indexed for MEDLINE]
9.

Abeta-2M-amyloidosis and related bone diseases.

Kazama JJ, Yamamoto S, Takahashi N, Ito Y, Maruyama H, Narita I, Gejyo F.

J Bone Miner Metab. 2006;24(2):182-4. Review.

PMID:
16502130
[PubMed - indexed for MEDLINE]
10.

Neuroprotection by flavonoids.

Dajas F, Rivera-Megret F, Blasina F, Arredondo F, Abin-Carriquiry JA, Costa G, Echeverry C, Lafon L, Heizen H, Ferreira M, Morquio A.

Braz J Med Biol Res. 2003 Dec;36(12):1613-20. Epub 2003 Nov 17. Review.

PMID:
14666245
[PubMed - indexed for MEDLINE]
Free Article
11.

Towards modeling of amyloid fibril structures.

Guo JT, Xu Y.

Front Biosci. 2008 May 1;13:4039-50. Review.

PMID:
18508498
[PubMed - indexed for MEDLINE]
12.

Kinetics and thermodynamics of amyloid fibril assembly.

Wetzel R.

Acc Chem Res. 2006 Sep;39(9):671-9. Review.

PMID:
16981684
[PubMed - indexed for MEDLINE]
13.

Using model membranes for the study of amyloid beta:lipid interactions and neurotoxicity.

Vestergaard M, Hamada T, Takagi M.

Biotechnol Bioeng. 2008 Mar 1;99(4):753-63. Review.

PMID:
17994591
[PubMed - indexed for MEDLINE]
14.

Sequence and structural determinants of amyloid fibril formation.

Bemporad F, Calloni G, Campioni S, Plakoutsi G, Taddei N, Chiti F.

Acc Chem Res. 2006 Sep;39(9):620-7. Review.

PMID:
16981678
[PubMed - indexed for MEDLINE]
15.

Quasielastic light scattering study of amyloid beta-protein fibril formation.

Lomakin A, Teplow DB.

Protein Pept Lett. 2006;13(3):247-54. Review.

PMID:
16515452
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk